brequinar has been researched along with Animal Mammary Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, SI; Amitrano, AM; Barbi, J; Colligan, SH; Kramer, ED; Morreale, B; Nemeth, MJ; Opyrchal, M; Peresie, J; Singh, PK; Sykes, DB; Wang, J; Yu, H; Zollo, RA | 1 |
1 other study(ies) available for brequinar and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression.
Topics: Animals; Breast Neoplasms; Female; Humans; Immunologic Factors; Immunotherapy; Mammary Neoplasms, Animal; Mice; Myeloid-Derived Suppressor Cells; Programmed Cell Death 1 Receptor | 2022 |